Related Experiment Video
Updated: May 5, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
Published on: June 4, 2012
Infective Endocarditis Caused by Streptococcus viridans in a Previously Healthy Man: A Case Report
Sara Fontaínhas1, Bárbara Baptista1, Maria I Bertão1
1Internal Medicine, Hospital Distrital da Figueira da Foz, Figueira da Foz, PRT.
Abstract:
Infective endocarditis (IE) is a rare and potentially fatal infection of the heart valves, often caused by streptococci, staphylococci, and enterococci. This case is particularly significant as it describes IE caused by Streptococcus viridans in a 36-year-old male patient, previously healthy with no known risk factors, who presented with a three-week history of fever, night sweats, and fatigue. Initially, the clinical presentation was attributed to an atypical infection due to his occupational exposure, and he was empirically treated with doxycycline, showing apparent clinical improvement. However, blood cultures were positive for Streptococcus viridans, leading to hospitalization and suspicion of endocarditis. Echocardiography revealed congenital aortic valvulopathy (bicuspid aortic valve) with moderate regurgitation but no evidence of vegetation. A transesophageal echocardiogram identified vegetations, confirming the diagnosis of IE. Treatment with ceftriaxone and gentamicin resulted in a favorable clinical response after four weeks. This case highlights the diagnostic challenges of IE in atypical presentations and the importance of considering IE in patients with fever and positive blood cultures, even in the absence of known cardiac disease or previous risk factors. It also emphasizes the need for timely diagnosis to prevent severe complications associated with endocarditis. The authors aim to underscore the indolent course of IE in this rare clinical presentation.
Related Concept Videos
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Rheumatic Heart Disease I: Introduction

